Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine
Clinical trial NCT00742885 · COMPLETED
Trial details
- NCT number
- NCT00742885
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2009-03-07
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.